Skip to main content

Chronicle AM: NIH Awards Grant to Study MedMJ and Opioids, Hawaii Dispensary Woes, More... (8/14/17)

Submitted by Phillip Smith on (Issue #986)
Consequences of Prohibition

The National Institute of Health is ready to see what impact medical marijuana can have on opioid use, Hawaii's first dispensary hits a (temporary) regulatory hurdle, human rights groups warn on the Philippines and Indonesia, and more.

Can medical marijuana help with chronic pain and reduce opioid dependence? NIH pays to find out. (Creative Commons)
Marijuana Policy

Marianas Islands Legalization Bill Refiled. Sen. Sixto Igisomar has refiled a marijuana legalization bill, Senate Bill 20-62. This version of the bill is not yet available on the Commonwealth of the Northern Marianas Islands legislative website, but last year's version is available here. The bill would not legalize marijuana by itself, but would allow a popular vote on the question: "Should the commonwealth legalize and regulate marijuana by approving the CNMI Cannabis Act of 2018?" If approved by a majority of voters, it would then become law.

Medical Marijuana

NIH Awards Grant to Study Marijuana and Opioid Addiction. The National Institute of Health last week awarded a $3.8 million grant to researchers at the Albert Einstein College of Medicine and Montefiore Health System to study the effects of medical marijuana on opioid use and addiction. The study will examine chronic pain patients suffering from HIV in hopes of developing rigorous evidence to back a growing number of anecdotal claims that marijuana can reduce the resort to opioid pain relievers and treat the associated pain.

Hawaii's First Dispensary Temporarily Shuttered By Bureaucratic Delays. Maui Grown Therapies, the state's first permitted medical marijuana dispensary, had to suspend sales just five days after opening due to supply issues because of delays at the Hawaii State Labs Division. The dispensary was set to begin sales to walk-in customers Monday, but now has to hold off until, it hopes, Wednesday.

International

Is Indonesia Embracing Philippines-Style Drug War? Death Toll Mounts. Amnesty International has reported that at least 55 people have been killed under an apparent "shoot on sight" policy aimed at drug offenders in the archipelago. The victims were killed "without judicial process," the human rights group noted. President Joko Widodo and National Police Chief General Tito Karnavian have repeatedly expressed frustration with drug trafficking and what they call lenient punishment for them. On June 21, Widodo reiterated an earlier order for law enforcement to shoot drug dealers without compunction.

Human Rights Watch Says Philippines Drug Testing of College Students Threatens Their Safety. The Philippines Commission on Higher Education has approved a plan for mandatory drug testing of college students, but Human Rights Watch warns that "mandatory drug testing of students puts them in the crosshairs of Duterte's abusive drug war, risking the creation of school-to-cemetery track for students testing positive for drugs." The rights group also scored the plan because it allows police to "carry out any drug-related operation within the school premises," allowing "police to extend their anti-drug operations to colleges and university campuses, putting students at grave risk." More than 8,000 people have been killed since President Duterte unleashed his brutal crackdown last year.

Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.

Comments

saynotohypocrisy (not verified)

He's fighting a war on drugs that aren't alcohol or tobacco. Filipinos who profit from those two killer drugs must be thrilled by his genocide against their competition.

Mon, 08/14/2017 - 11:28pm Permalink

Add new comment

The content of this field is kept private and will not be shown publicly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.